glp-1 after bariatric surgery Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain surgery: a Retrospective Observational Study Tired of GLP-1s? Comparing Gastric

Chen BD, Zhao WC, Dong JD, Sima H

Abbreviations BGM Blood glucose monitoring CGM Continuous glucose monitoring CSII Continuous subcutaneous insulin infusion CVOT Cardiovascular outcomes trial DKA Diabetic ketoacidosis DPP-4i Dipeptidyl peptidase-4 inhibitors DSMES Diabetes self-management education and support ETD Estimated treatment difference GIP Glucose-dependent insulinotropic polypeptide GLP-1 RA Glucagon-like peptide-1 receptor agonist(s) HF Heart failure HHF Hospitalisation for heart failure MACE Major adverse cardiovascular events MNT Medical nutrition therapy NAFLD Non-alcoholic fatty liver disease NASH Non-alcoholic steatohepatitis SGLT1i Sodiumglucose cotransporter-1 inhibitor SGLT2i Sodiumglucose cotransporter-2 inhibitor(s) TZD Thiazolidinedione UACR Urinary albumin/creatinine ratio Funding This activity was funded by the American Diabetes Association and the European Association for the Study of Diabetes

What Happens When You Stop GLP-1 Therapy

Medicare Advantage: cost-share depends on plan tier